Demoruelle MK, Weisman MH, Simonian PL, Lynch DA, Sachs PB, Pedraza IF, Harrington AR, Kolfenbach JR, Striebich CC, Pham QN, Strickland CD, Petersen BD, Parish MC, Derber LA, Norris JM, Holers VM, Deane KD: Airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: Early injury or initiating site of autoimmunity?. Arthritis Rheum. 2012, 64: 1756-1761.
Article
CAS
PubMed
PubMed Central
Google Scholar
Eyre S, Bowes J, Diogo D, Lee A, Barton A, Martin P, Zhernakova A, Stahl E, Viatte S, McAllister K, Amos CI, Padyukov L, Toes RE, Huizinga TW, Wijmenga C, Trynka G, Franke L, Westra HJ, Alfredsson L, Hu X, Sandor C, de Bakker PI, Davila S, Khor CC, Heng KK, Andrews R, Edkins S, Hunt SE, Langford C, Symmons D: High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet. 2012, 44: 1336-1340. 10.1038/ng.2462.
Article
CAS
PubMed
PubMed Central
Google Scholar
Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, Ronnelid J, Harris HE, Ulfgren AK, Rantapaa-Dahlqvist S, Eklund A, Padyukov L, Alfredsson L: A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006, 54: 38-46. 10.1002/art.21575.
Article
CAS
PubMed
Google Scholar
Brink M, Hansson M, Mathsson L, Jakobsson PJ, Holmdahl R, Hallmans G, Stenlund H, Ronnelid J, Klareskog L, Dahlqvist SR: Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. Arthritis Rheum. 2013, 65: 899-910. 10.1002/art.37835.
Article
CAS
PubMed
Google Scholar
Kokkonen H, Soderstrom I, Rocklov J, Hallmans G, Lejon K, Rantapaa Dahlqvist S: Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum. 2010, 62: 383-391.
CAS
PubMed
Google Scholar
Rantapää-Dahlqvist S, de Jong BAW, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ: Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003, 48: 2741-2749. 10.1002/art.11223.
Article
PubMed
Google Scholar
Sokolove J, Bromberg R, Deane KD, Lahey LJ, Derber LA, Chandra PE, Edison JD, Gilliland WR, Tibshirani RJ, Norris JM, Holers VM, Robinson WH: Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One. 2012, 7: e35296-10.1371/journal.pone.0035296.
Article
CAS
PubMed
PubMed Central
Google Scholar
Deane KD, O’Donnell CI, Hueber W, Majka DS, Lazar AA, Derber LA, Gilliland WR, Edison JD, Norris JM, Robinson WH, Holers VM: The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum. 2010, 62: 3161-3172. 10.1002/art.27638.
Article
CAS
PubMed
PubMed Central
Google Scholar
Conway EM, Pollefeyt S, Cornelissen J, DeBaere I, Steiner-Mosonyi M, Ong K, Baens M, Collen D, Schuh AC: Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions. Blood. 2000, 95: 1435-1442.
CAS
PubMed
Google Scholar
Svensson MN, Andersson SE, Erlandsson MC, Jonsson IM, Ekwall AK, Andersson KM, Nilsson A, Bian L, Brisslert M, Bokarewa MI: Fms-like tyrosine kinase 3 ligand controls formation of regulatory T cells in autoimmune arthritis. PLoS One. 2013, 8: e54884-10.1371/journal.pone.0054884.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bokarewa M, Lindblad S, Bokarew D, Tarkowski A: Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Arthritis Res Ther. 2005, 7: R349-R358. 10.1186/ar1498.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dehlin M, Bokarewa M, Rottapel R, Foster SJ, Magnusson M, Dahlberg LE, Tarkowski A: Intra-articular fms-like tyrosine kinase 3 ligand expression is a driving force in induction and progression of arthritis. PLoS One. 2008, 3: e3633-10.1371/journal.pone.0003633.
Article
PubMed
PubMed Central
Google Scholar
Svensson B, Hafstrom I, Forslind K, Albertsson K, Tarkowski A, Bokarewa M: Increased expression of proto-oncogene survivin predicts Joint destruction and persistent disease activity in early rheumatoid arthritis. Ann Med. 2010, 42: 45-54. 10.3109/07853890903376280.
Article
CAS
PubMed
Google Scholar
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS: The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002/art.1780310302.
Article
CAS
PubMed
Google Scholar
Andersson SE, Svensson MN, Erlandsson MC, Dehlin M, Andersson KM, Bokarewa MI: Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis. PLoS One. 2012, 7: e47668-10.1371/journal.pone.0047668.
Article
CAS
PubMed
PubMed Central
Google Scholar
Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, Van Venrooij WJ, Klareskog L, Dahlqvist SR: A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther. 2004, 6: R303-R308. 10.1186/ar1187.
Article
CAS
PubMed
PubMed Central
Google Scholar
Erlandsson MC, Forslind K, Andersson SE, Lund A, Bokarewa MI: Metastasin S100A4 is increased in proportion to radiographic damage in patients with RA. Rheumatol (Oxford). 2012, 51: 932-940. 10.1093/rheumatology/ker362.
Article
CAS
Google Scholar
Isgren A, Forslind K, Erlandsson M, Axelsson C, Andersson S, Lund A, Bokarewa M: High survivin levels predict poor clinical response to infliximab treatment in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2012, 41: 652-657. 10.1016/j.semarthrit.2011.08.005.
Article
CAS
PubMed
Google Scholar
Okada H, Bakal C, Shahinian A, Elia A, Wakeham A, Suh WK, Duncan GS, Ciofani M, Rottapel R, Zuniga-Pflucker JC, Mak TW: Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death. J Exp Med. 2004, 199: 399-410. 10.1084/jem.20032092.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xing Z, Conway EM, Kang C, Winoto A: Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis. J Exp Med. 2004, 199: 69-80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Song J, Lei FT, Xiong X, Haque R: Intracellular signals of T cell costimulation. Cell Mol Immunol. 2008, 5: 239-247. 10.1038/cmi.2008.30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kornacker M, Verneris MR, Kornacker B, Scheffold C, Negrin RS: Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells. Immunol Lett. 2001, 76: 169-173. 10.1016/S0165-2478(01)00186-9.
Article
CAS
PubMed
Google Scholar
Ahn JK, Oh JM, Lee J, Bae EK, Ahn KS, Cha HS, Koh EM: Increased extracellular survivin in the synovial fluid of rheumatoid arthritis patients: fibroblast-like synoviocytes as a potential source of extracellular survivin. Inflammation. 2010, 33: 381-388. 10.1007/s10753-010-9196-1.
Article
CAS
PubMed
Google Scholar
Baran M, Mollers LN, Andersson S, Jonsson IM, Ekwall AK, Bjersing J, Tarkowski A, Bokarewa M: Survivin is an essential mediator of arthritis interacting with urokinase signalling. J Cell Mol Med. 2009, 13: 3797-3808. 10.1111/j.1582-4934.2009.00721.x.
Article
PubMed
PubMed Central
Google Scholar
Dharmapatni AA, Smith MD, Findlay DM, Holding CA, Evdokiou A, Ahern MJ, Weedon H, Chen P, Screaton G, Xu XN, Haynes DR: Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium. Arthritis Res Ther. 2009, 11: R13-10.1186/ar2603.
Article
PubMed
PubMed Central
Google Scholar
Smith MD, Weedon H, Papangelis V, Walker J, Roberts-Thomson PJ, Ahern MJ: Apoptosis in the rheumatoid arthritis synovial membrane: modulation by disease-modifying anti-rheumatic drug treatment. Rheumatol (Oxford). 2010, 49: 862-875. 10.1093/rheumatology/kep467.
Article
CAS
Google Scholar
van de Sande MG, de Hair MJ, van der Leij C, Klarenbeek PL, Bos WH, Smith MD, Maas M, de Vries N, van Schaardenburg D, Dijkmans BA, Gerlag DM, Tak PP: Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann Rheum Dis. 2011, 70: 772-777. 10.1136/ard.2010.139527.
Article
CAS
PubMed
Google Scholar
Swee LK, Bosco N, Malissen B, Ceredig R, Rolink A: Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment. Blood. 2009, 113: 6277-6287. 10.1182/blood-2008-06-161026.
Article
CAS
PubMed
Google Scholar
Dehlin M, Andersson S, Erlandsson M, Brisslert M, Bokarewa M: Inhibition of fms-like tyrosine kinase 3 alleviates experimental arthritis by reducing formation of dendritic cells and antigen presentation. J Leukoc Biol. 2011, 90: 811-817. 10.1189/jlb.1110640.
Article
CAS
PubMed
Google Scholar
Perumal NB, Kaplan MH: Regulating Il9 transcription in T helper cells. Trends Immunol. 2011, 32: 146-150. 10.1016/j.it.2011.01.006.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vignali DA, Kuchroo VK: IL-12 family cytokines: immunological playmakers. Nat Immunol. 2012, 13: 722-728. 10.1038/ni.2366.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gordon S, Martinez FO: Alternative activation of macrophages: mechanism and functions. Immunity. 2010, 32: 593-604. 10.1016/j.immuni.2010.05.007.
Article
CAS
PubMed
Google Scholar
Goodnow CC, Vinuesa CG, Randall KL, Mackay F, Brink R: Control systems and decision making for antibody production. Nat Immunol. 2010, 11: 681-688.
Article
CAS
PubMed
Google Scholar